冠状动脉CTA在原位心脏移植受者中的长期预后价值
回顾性分析114例心脏移植受者(平均年龄61.7±11.1岁,83.3%为男性)于2007年6月至2017年12月因监测冠状动脉移植物血管病(CAV)行冠状动脉CTA,随访平均67.5±41.4个月。阻塞性CAV(管腔狭窄≥50%)者主要不良心血管事件(MACE)发生率为50%,非阻塞性CAV者为14.7%(p<.05),OR为6(95%CI 1.7-21.2),HR为5(95%CI 1.95-13;p=.004);狭窄冠状动脉节段≥4个(SIS≥4)与事件率升高相关(HR 3.46;95%CI 1.46-8.23)。结论认为CCTA对心脏移植受者MACE的长期预测具有显著预后价值。
要点
- 阻塞性CAV(管腔狭窄≥50%)者MACE发生率50%,非阻塞性CAV者14.7%,OR 6(95%CI 1.7-21.2)。
- 阻塞性病变者无事件生存HR 5(95%CI 1.95-13;p=.004)。
- SIS≥4与事件率升高相关(HR 3.46;95%CI 1.46-8.23)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. This study aimed to evaluate the long-term prognostic value of coronary CTA (CCTA) in heart transplant recipients. MATERIALS AND METHODS. The records of 114 patients who had undergone a heart transplant (mean age, 61.7 ± 11.1 [SD] years; 83.3% men) and who underwent CCTA for the surveillance of coronary allograft vasculopathy (CAV) from June 2007 to December 2017 were retrospectively evaluated for the occurrence of major adverse cardiovascular events (MACEs) (cardiac death, nonfatal myocardial infarction, unstable angina requiring hospitalization, coronary revascularization, cardiac arrhythmias, stroke, and retransplant). Patients were classified according to the presence of nonobstructive CAV (lumen reduction < 50%) or obstructive disease (lumen reduction ≥ 50%) and using a coronary segment involvement score (SIS). Differences in MACE rate between groups were compared. RESULTS. Obstructive CAV was observed in 12 heart transplant recipients (10.5%). During a mean follow-up of 67.5 ± 41.4 months the overall rates of MACE were 50% and 14.7% in patients with obstructive and nonobstructive CAV, respectively (p < .05), resulting in an odds ratio for MACE of 6 (95% CI, 1.7-21.2). Comparison of event-free survival showed a hazard ratio (HR) of 5 (95% CI, 1.95-13; p =. 004) for patients with obstructive disease. The presence of four or more stenotic coronary segments (SIS ≥ 4) was associated with a higher rate of events (HR, 3.46; 95% CI, 1.46-8.23). CONCLUSION. In patients who have undergone a heart transplant, CCTA offers a significant long-term prognostic impact on the prediction of MACEs.
引用
- García-Baizán A, Caballeros M, Ezponda A, et al. Long-Term Prognostic Value of Coronary CTA in Orthotopic Heart Transplant Recipients. AJR Am J Roentgenol. 2021. PMID: 33624522. doi:10.2214/AJR.20.23535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。